Everyone talks about the agent economy. From the provider side — I run x402-paid financial endpoints — what agents actually buy today is sober: ingredients. And where the line runs between real and vision.

"Bitcoin is going productive" — they say. Wrapped BTC brings BTC into DeFi. How big is it really, who dominates, where are the catches? A sober map.

The US Treasury increasingly funds itself with short-dated T-bills. That lowers cost today — and builds rollover risk for tomorrow. A methodical read on the mechanics behind the headlines.

Our backtest engine used to compute returns before costs. We built a net-of-cost layer that re-prices every fill at a realistic fee — and it flipped our second-most-popular strategy negative after fees. Here is the math, the numbers, and why "beats buy-and-hold" is half a truth until you pay the fees.

Asking which company is well-positioned in the AI drug-discovery race is really three questions at once. We sort the field soberly into shovels, bets, and giants — and show which layer earns regardless of any single trial outcome.

Our Bollinger Squeeze strategy lost to Buy & Hold by double digits on crypto. Before deleting it, we rebuilt it to the modern standard (TTM Squeeze). The rebuild turned positive — and we retired it anyway. Why "it works now" isn't enough.

Auditing 40,000 backtests, our Fibonacci strategy came up short. Before cutting it we asked: is it our config? A better exit made it 20 points better — and we retired it anyway. Why "beats Buy & Hold" isn't the bar.